<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">There are four known DENV serotypes which are genetically and antigenically distinct, and each one is able to cause clinical manifestations ranging from asymptomatic infections to severe disease or even death
 <sup>
  <xref ref-type="bibr" rid="CR7">7</xref>,
  <xref ref-type="bibr" rid="CR8">8</xref>
 </sup>. DENV infections by any serotype induce protective immune responses against subsequent infections with the same serotype, whereas heterotypic secondary infections may lead to exacerbated viral multiplication and the development of severe disease
 <sup>
  <xref ref-type="bibr" rid="CR9">9</xref>–
  <xref ref-type="bibr" rid="CR11">11</xref>
 </sup>. The 
 <italic>Zika virus</italic> (ZIKV) (a closely related flavivirus) emergence in areas where other flaviviruses circulate brought a significant burden to an already complicated scenario, in which affected countries must frequently cope with yellow fever, dengue and epidemics caused by other arboviruses. This is especially true after the recent ZIKV outbreaks in the Americas revealed an association of the infection to the occurrence of neurological malformations in fetuses from infected mothers and neurogenic demyelinating diseases such as the Guillain–Barre syndrome
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>.
</p>
